Inogen | INGN - Assets


Inogen reported $307.01M in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Abbott USD 110.43B 23.72B Mar/2026
Accuray USD 448.01M 8.81M Dec/2025
AngioDynamics USD 269.68M 4.04M Sep/2025
Artivion USD 1.07B 188.78M Jun/2026
AtriCure USD 676.64M 32.66M Jun/2026
Baxter International USD 19.79B 55M Jun/2026
Becton, Dickinson and Co. USD 50.73B 101M Jun/2026
Boston Scientific USD 45.22B 865M Jun/2026
Cooper Companies USD 12.48B 58.1M Mar/2026
Dexcom USD 6.46B 178M Jun/2026
Edwards Lifesciences USD 13.87B 545.9M Jun/2026
Globus Medical USD 5.49B 48.7M Jun/2026
Inogen USD 307.01M 5.03M Sep/2025
Insulet USD 3.17B 177.9M Jun/2026
Medtronic USD 91.48B 139M Dec/2025
Orthofix International USD 873.02M 13.58M Jun/2026
Philips EUR 26.7B 565M Jun/2026
ResMed USD 8.97B 181.66M Jun/2026
Steris USD 10.74B 1.1M Jun/2026
Stryker USD 47.93B 1.64B Jun/2026
Tandem Diabetes Care USD 1.15B 808K Jun/2026
Teleflex USD 6.79B 3.78M Jun/2026
X T L Biopharmaceuticals USD 166K 548K Dec/2025
Zimmer Biomet Holdings USD 22.8B 76.2M Jun/2026